Genmab · 22 hours ago
Director, Feasibility Lead
Plainsboro, NJ
Full-time
Hybrid
Director/Executive
$183K/yr - $275K/yr
8+ years expGenmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Director, Feasibility Lead will drive strategic feasibility practices to optimize clinical trial design and delivery, balancing operational ownership with leadership responsibilities.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Lead the end-to-end feasibility process for priority or complex development programs, including early indication assessments, country and site selection, patient recruitment forecasting, and operational risk analysis
Serve as a senior strategic partner to Development Operations (DevOps), Clinical Strategy and external partners to inform study design and operational delivery strategies
Shape feasibility approaches and standards by incorporating internal and external data sources, novel technologies, and evolving regulatory and business needs
Mentor and provide strategic guidance to Associate Directors and other feasibility team members; contribute to capability-building across the function
Drive cross-functional planning sessions related to feasibility strategy, scenario modeling, country allocation, PI identification and enrollment planning
Represent Strategic Feasibility in key governance and decision-making forums, effectively communicating insights, risks, and recommendations
Identify opportunities for continuous improvement and lead or support change initiatives at the intersection of process, technology, and data science
Partner with the Head of Strategic Feasibility on function-wide priorities such as resourcing, standards, and vendor strategy
Qualification
Required
Minimum BS/BA required
Fluent in spoken and written English
8–10+ years of experience in clinical drug development, including significant experience in feasibility within pharmaceutical, biotech, or CRO settings
Proven leadership of complex, global feasibility initiatives and ability to influence clinical development strategy
Track record of cross-functional leadership in matrixed environments
Experience mentoring or managing colleagues, even in an informal or project-based capacity
Proficiency in feasibility-related analytics, competitive intelligence, operational scenario planning, and stakeholder engagement
Strategic thinker who also executes with precision
Exceptional communication and facilitation skills, with a global mindset
Curious, solution-oriented, and collaborative by nature
Adept at working independently while balancing competing priorities
Embraces innovation and continuous improvement
Demonstrates self-awareness and supports team development through feedback and coaching
Preferred
Advanced degree preferred
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
1001-5000 employees
H1B Sponsorship
Genmab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
pharmaphorum
2026-01-03
Clinical Trials Arena
2026-01-03
2025-12-31
Company data provided by crunchbase